• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ganirelix Taro 0.25 mg/0.5 ml
    / Taro International Ltd


    Active Ingredient
    Ganirelix 0.25 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Solution for Injection

    1 X 0.5 ml

    partial basket chart 37637 24544

    Dosage

    This drug should only be prescribed by a specialist experienced in the treatment of infertility.


    Indications

    Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian stimulation in the setting of fertility treatments.


    Contra-Indications

    * Hypersensitivity to the active substance or to any of the excipients
    * Hypersensitivity to gonadotrophin-releasing homrone (GnRH) or any other GnRH analogue
    * Moderate or severe impairment of renal or hepatic function
    * Pregnancy or lactation.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Manufacturer
    SUN Pharmaceutical Industries LTD., India

    סרגל נגישות

    CLOSE